Tower Research Capital LLC (Trc) Innoviva, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Innoviva, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,962 shares of INVA stock, worth $87,083. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,962
Previous 2,834
75.09%
Holding current value
$87,083
Previous $54,000
59.26%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding INVA
# of Institutions
243Shares Held
77.7MCall Options Held
52.8KPut Options Held
800-
Black Rock Inc. New York, NY9.63MShares$169 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$128 Million39.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$111 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$110 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.92MShares$86.3 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.22B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...